In a 175‑lb adult with persistent fatigue, snoring, dry mouth, mild restless‑legs symptoms, an Epworth Sleepiness Scale score of 6, and a polysomnography showing an apnea‑hypopnea index of approximately 1.6 and lowest oxygen saturation of 87%, what is the appropriate management regarding CPAP use, laboratory evaluation, and treatment of restless‑legs syndrome?

Management Recommendation

CPAP is not indicated for this patient given the AHI of 1.6, which does not meet diagnostic criteria for obstructive sleep apnea; instead, focus should be on treating the restless legs syndrome with iron studies followed by gabapentin or pregabalin, and addressing the persistent fatigue through evaluation of other causes.

Obstructive Sleep Apnea Assessment

This patient does not have OSA requiring treatment. The home sleep test revealed:

• AHI of 1.6 (normal is <5)
• Only 2 obstructive apneas, 8 central apneas, and 6 hypopneas
• Lowest oxygen saturation of 87%

No CPAP therapy is warranted 1. The 2019 AASM guideline for PAP therapy assumes a diagnosis of OSA has already been established before considering treatment initiation. With an AHI of 1.6, this patient does not meet diagnostic thresholds for OSA (mild OSA requires AHI ≥5).

Key Pitfall to Avoid

The single desaturation to 87% in isolation does not justify CPAP. This could represent a positional event, artifact, or brief respiratory event that did not meet scoring criteria for significant sleep-disordered breathing.

Restless Legs Syndrome Management

The patient's symptoms are classic for RLS: hot, uncomfortable, tingly sensations in the legs, worse with immobility, relieved by movement and rubbing feet, more pronounced in the evening. This is the primary driver of her non-restorative sleep and persistent fatigue.

Step 1: Laboratory Evaluation (Mandatory)

Obtain morning fasting iron studies immediately 2:

• Serum ferritin
• Iron and total iron binding capacity (to calculate transferrin saturation)
• Patient must avoid iron-containing supplements and foods for 24 hours before blood draw

Treatment thresholds differ from general population 2:

• If ferritin ≤75 ng/mL OR transferrin saturation <20%: Start oral or IV iron
• If ferritin 75-100 ng/mL: Consider IV iron only
• These are RLS-specific thresholds, not standard anemia thresholds

Step 2: Address Exacerbating Factors

Review and modify 2:

• Prozac (fluoxetine) is serotonergic and can worsen RLS—discuss with prescriber about alternatives or dose reduction if feasible given anxiety control
• Caffeine (2 cups/day)—consider reduction
• Weekend alcohol use—counsel on potential worsening of symptoms

Step 3: Pharmacologic Treatment

Based on the 2025 AASM guidelines, first-line pharmacologic options (strong recommendations with moderate certainty) 2:

1. Gabapentin (strong recommendation, moderate certainty)
2. Gabapentin enacarbil (strong recommendation, moderate certainty)
3. Pregabalin (strong recommendation, moderate certainty)

Start with gabapentin or pregabalin as these have the strongest evidence and avoid the augmentation risk associated with dopamine agonists.

Critical Caveat: Avoid Dopamine Agonists as First-Line

The 2025 AASM guidelines now suggest against standard use of pramipexole, ropinirole, and rotigotine due to augmentation risk (worsening of symptoms with long-term use) 2. These may only be considered in patients who value short-term symptom reduction over long-term adverse effects.

Addressing Persistent Fatigue

With OSA ruled out and RLS identified, evaluate other causes:

• Medication effect: Prozac can cause fatigue
• Sleep hygiene: Weekend bedtime shift (12 AM vs 10:30-11 PM weekdays) may contribute
• Underlying mood disorder: Anxiety itself or suboptimal treatment
• Other medical causes: Consider thyroid function, vitamin D, B12 if not recently checked

The non-restorative sleep is likely multifactorial: RLS disrupting sleep architecture plus potential medication effects.

Follow-Up Plan

1. Order iron studies today with morning fasting draw
2. Initiate gabapentin or pregabalin for RLS symptoms (dosing per standard protocols, typically starting low and titrating)
3. Consider iron supplementation based on results (oral ferrous sulfate if ferritin ≤75 or TSAT <20%; IV ferric carboxymaltose if ferritin 75-100) 2
4. Coordinate with psychiatry regarding Prozac and its potential contribution to both fatigue and RLS
5. Reassess in 4-6 weeks for symptom improvement and medication tolerability
6. No sleep study follow-up needed unless new symptoms develop suggesting OSA

Note on RLS-OSA Comorbidity

While recent research shows that treating OSA with CPAP can improve RLS symptoms in patients with both conditions 3, 4, 5, 6, this patient does not have OSA to treat. The research demonstrating RLS improvement with CPAP applies only to patients with confirmed OSA (typically AHI ≥15-30 in these studies), not to patients with normal sleep studies like this one.